Literature DB >> 33375986

Impacts of COVID-19 on residential treatment programs for substance use disorder.

Anna Pagano1, Sindhu Hosakote2, Kwinoja Kapiteni2, Elana R Straus2, Jessie Wong2, Joseph R Guydish2.   

Abstract

INTRODUCTION: The COVID-19 pandemic may present special challenges for residential substance use disorder (SUD) treatment facilities, which may lack infrastructure and support to implement infection control protocols while maintaining on-site treatment services. However, little is known about how residential SUD treatment programs are impacted by the COVID-19 pandemic.
METHODS: The research team conducted semi-structured interviews with 17 directors of 20 residential SUD treatment programs across California during the state's shelter-in-place order. The researchers then analyzed qualitative interview data thematically and coded them using ATLAS.ti software.
FINDINGS: Thematic analyses identified six major themes: program-level impacts, staff impacts, client impacts, use of telehealth, program needs, and positive effects. "Program-level impacts" were decreased revenue from diminished client censuses and insufficient resources to implement infection control measures. "Staff impacts" included layoffs, furloughs, and increased physical and emotional fatigue. "Client impacts" were delayed treatment initiation; receipt of fewer services while in treatment; lower retention; and economic and psychosocial barriers to community re-entry. "Use of telehealth" included technical and interpersonal challenges associated with telehealth visits. "Program needs" were personal protective equipment (PPE), stimulus funding, hazard pay, and consistent public health guidance. "Positive effects" of the pandemic response included increased attention to hygiene and health, telehealth expansion, operational improvements, and official recognition of SUD treatment as an essential health care service.
CONCLUSION: Study findings highlight COVID-related threats to the survival of residential SUD treatment programs; retention of the SUD treatment workforce; and clients' SUD treatment outcomes. These findings also identify opportunities to improve SUD service delivery and suggest avenues of support for residential SUD treatment facilities during and after the COVID-19 pandemic.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COVID-19; Disaster; Pandemic; Residential; Substance use disorder; Treatment

Mesh:

Year:  2020        PMID: 33375986      PMCID: PMC7953585          DOI: 10.1016/j.jsat.2020.108255

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  33 in total

1.  Does retention matter? Treatment duration and improvement in drug use.

Authors:  Zhiwei Zhang; Peter D Friedmann; Dean R Gerstein
Journal:  Addiction       Date:  2003-05       Impact factor: 6.526

2.  Big Events and Risks to Global Substance Using Populations: Unique Threats and Common Challenges.

Authors:  Tim K Mackey; Steffanie A Strathdee
Journal:  Subst Use Misuse       Date:  2015-02-27       Impact factor: 2.164

Review 3.  Peer recovery support for individuals with substance use disorders: assessing the evidence.

Authors:  Sharon Reif; Lisa Braude; D Russell Lyman; Richard H Dougherty; Allen S Daniels; Sushmita Shoma Ghose; Onaje Salim; Miriam E Delphin-Rittmon
Journal:  Psychiatr Serv       Date:  2014-07       Impact factor: 3.084

4.  The Challenge of Preventing COVID-19 Spread in Correctional Facilities.

Authors:  Rita Rubin
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

5.  Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment.

Authors:  Traci C Green; Jeffrey Bratberg; Deborah S Finnell
Journal:  Subst Abus       Date:  2020       Impact factor: 3.716

6.  Telemedicine-delivered treatment interventions for substance use disorders: A systematic review.

Authors:  Lewei Allison Lin; Danielle Casteel; Erin Shigekawa; Meghan Soulsby Weyrich; Dylan H Roby; Sara B McMenamin
Journal:  J Subst Abuse Treat       Date:  2019-03-21

7.  Isolating the isolated: Implications of COVID-19 quarantine measures on in-patient detoxification treatment for substance use disorders.

Authors:  Paola Rosca; Barak Shapira; Yehuda Neumark
Journal:  Int J Drug Policy       Date:  2020-07-06

8.  Depression, anxiety, stress levels of physicians and associated factors in Covid-19 pandemics.

Authors:  Rümeysa Yeni Elbay; Ayşe Kurtulmuş; Selim Arpacıoğlu; Emrah Karadere
Journal:  Psychiatry Res       Date:  2020-05-27       Impact factor: 3.222

9.  The impending storm: COVID-19, pandemics and our overwhelmed emergency departments.

Authors:  Darren P Mareiniss
Journal:  Am J Emerg Med       Date:  2020-03-23       Impact factor: 2.469

10.  Prevalence of Covid-19 Infection and Subsequent Cohorting in a Residential Substance Use Treatment Program in Boston, MA.

Authors:  Joshua A Barocas; Elizabeth Blackstone; Tara C Bouton; Simeon D Kimmel; Andrea Caputo; Sarah J Porter; Alexander Y Walley
Journal:  J Addict Med       Date:  2020 Sep/Oct       Impact factor: 4.647

View more
  13 in total

1.  Mixed methods prospective findings of the initial effects of the U.S. COVID-19 pandemic on individuals in recovery from substance use disorder.

Authors:  Katherine Shircliff; Melissa Liu; Christiana Prestigiacomo; Melissa Fry; Kevin Ladd; Misty Kannapel Gilbert; Mary Jo Rattermann; Melissa A Cyders
Journal:  PLoS One       Date:  2022-07-01       Impact factor: 3.752

2.  Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs.

Authors:  Fiona N Conway; Jake Samora; Katlyn Brinkley; Haelim Jeong; Nina Clinton; Kasey R Claborn
Journal:  Harm Reduct J       Date:  2022-07-02

3.  Understanding the Effect of the COVID-19 Pandemic on Substance Use Disorder Treatment Facility Operations and Patient Success: Evidence From Mississippi.

Authors:  Devon Meadowcroft; Will Davis
Journal:  Subst Abuse       Date:  2022-05-13

Review 4.  Strategies Adopted by Addiction Facilities during the Coronavirus Pandemic to Support Treatment for Individuals in Recovery or Struggling with a Substance Use Disorder: A Scoping Review.

Authors:  Divane de Vargas; Caroline Figueira Pereira; Rosa Jacinto Volpato; Ana Vitória Corrêa Lima; Rogério da Silva Ferreira; Sheila Ramos de Oliveira; Thiago Faustino Aguilar
Journal:  Int J Environ Res Public Health       Date:  2021-11-18       Impact factor: 4.614

Review 5.  Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments.

Authors:  Osnat C Melamed; Wayne K deRuiter; Leslie Buckley; Peter Selby
Journal:  Psychiatr Clin North Am       Date:  2021-11-12

6.  Concerns among people who use opioids during the COVID-19 pandemic: a natural language processing analysis of social media posts.

Authors:  Abeed Sarker; Nisha Nataraj; Wesley Siu; Sabrina Li; Christopher M Jones; Steven A Sumner
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-03-05

7.  Impact of COVID-19 Among People Who Use Drugs: A Qualitative Study With Harm Reduction Workers and People Who Use Drugs.

Authors:  Fiona N Conway; Jake Samora; Katlyn Brinkley; Haelim Jeong; Nina Clinton; Kasey R Claborn
Journal:  Res Sq       Date:  2022-02-04

8.  Using qualitative, community-based input to steer post-coronavirus disease 2019 pharmacy practice in substance use.

Authors:  Lucas Kosobuski; Andrew Hawn; Katelyn France; Nathaniel Chen; Cierra LaPlante; Laura Palombi
Journal:  J Am Pharm Assoc (2003)       Date:  2022-03-19

9.  Client perspectives on the accessibility and quality of substance use treatment during the COVID-19 pandemic.

Authors:  Randolph D Hubach; Andrew M O'Neil; Campbell Ernst; Mollie Stowe; Mark Hickey; Molly Remondino; Zachary Giano
Journal:  Drug Alcohol Depend Rep       Date:  2021-11-22

10.  COVID-19 vaccine trust among clients in a sample of California residential substance use treatment programs.

Authors:  Carmen L Masson; Caravella McCuistian; Elana Straus; Sania Elahi; Maggie Chen; Valerie A Gruber; Thao Le; Joseph Guydish
Journal:  Drug Alcohol Depend       Date:  2021-06-18       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.